Long-term quality of life outcome after proton beam monotherapy for localized prostate cancer.
about
Proton therapy for early stage prostate cancer: is there a case?Patient-reported urinary incontinence following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer.Quality of life and toxicity from passively scattered and spot-scanning proton beam therapy for localized prostate cancer.Quality of Life and Toxicity after SBRT for Organ-Confined Prostate Cancer, a 7-Year Study.Comparative cost-effectiveness of stereotactic body radiation therapy versus intensity-modulated and proton radiation therapy for localized prostate cancer.Patient-reported outcomes after 3-dimensional conformal, intensity-modulated, or proton beam radiotherapy for localized prostate cancer.Systematic review of hypofractionated radiation therapy for prostate cancer.Clinical controversies: proton therapy for prostate cancer.Hypofractionated passively scattered proton radiotherapy for low- and intermediate-risk prostate cancer is not associated with post-treatment testosterone suppression.Proton beam radiation therapy for prostate cancer-is the hype (and the cost) justified?Evolution of advanced technologies in prostate cancer radiotherapy.The effect of anterior proton beams in the setting of a prostate-rectum spacer.Intensity-Modulated Radiation Therapy with Stereotactic Body Radiation Therapy Boost for Unfavorable Prostate Cancer: The Georgetown University Experience.Hypofractionated radiotherapy for organ-confined prostate cancer: is less more?Erectile function, incontinence, and other quality of life outcomes following proton therapy for prostate cancer in men 60 years old and younger.Urinary functional outcomes and toxicity five years after proton therapy for low- and intermediate-risk prostate cancer: results of two prospective trials.Long-term quality of life outcomes in patients with locally advanced prostate cancer after intensity-modulated radiotherapy combined with androgen deprivation.Degradation of target coverage due to inter-fraction motion during intensity-modulated proton therapy of prostate and elective targets.
P2860
Q28072657-C209B807-A116-4204-872B-F2A387119852Q33851417-63737C8E-0B60-44E8-93B8-CC234248119CQ33864141-56D7BCA4-C39E-43ED-9A00-4B121E2AAF1DQ34413524-536D00E3-0ECD-411E-9407-8E842E7BF863Q36174829-E90BC4DC-7AC6-41EF-9550-C6C30C3F9F77Q37139334-231E0B1E-C039-4460-AF40-1F434BE90CD9Q37324126-444CD987-4B05-47B2-9F2B-2048273002CEQ38087711-8F6438AD-2B9C-461C-8163-1EC47D78B5C6Q38087988-1AC4F773-DCE9-4FD9-8D1E-10CC79E2945EQ38095001-5B57BC80-C0EC-40D1-8390-5033E55D312FQ38135708-ABB5E4F4-56E2-43D5-8579-82497C9FB9D1Q38548789-564C76EB-00CE-4481-8A6A-5BB7EE255EABQ38839208-C846614C-6641-4255-964C-73679D5413BCQ38863898-374275E4-F109-447A-951A-6F6935FD90ACQ42474370-4371176E-F676-414B-9F6D-83EFFF110E7AQ42709732-69F7FDC1-5E72-4A09-9301-1232BD81BF61Q48075768-ED363FE3-1FDA-403F-BD1C-8C1B6BCC76B2Q53120786-F3F0B703-92C5-4593-A3B3-DC403422BCA7
P2860
Long-term quality of life outcome after proton beam monotherapy for localized prostate cancer.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Long-term quality of life outc ...... for localized prostate cancer.
@en
Long-term quality of life outc ...... for localized prostate cancer.
@nl
type
label
Long-term quality of life outc ...... for localized prostate cancer.
@en
Long-term quality of life outc ...... for localized prostate cancer.
@nl
prefLabel
Long-term quality of life outc ...... for localized prostate cancer.
@en
Long-term quality of life outc ...... for localized prostate cancer.
@nl
P2093
P1476
Long-term quality of life outc ...... for localized prostate cancer.
@en
P2093
Andrzej Niemierko
Anita Rodrigues
Anthony L Zietman
James A Talcott
John J Coen
Jonathan J Paly
William U Shipley
P304
P356
10.1016/J.IJROBP.2011.03.048
P407
P577
2011-05-27T00:00:00Z